Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most patents in Sweden. Patents must be filed in each country (or, […]
Source
Which pharmaceutical companies have the most drug patents in Sweden? Read Post »
The value proposition of Contract Development and Manufacturing Organizations (CDMOs) has become increasingly crucial in the pharmaceutical industry. As the […]
Source
In the pharmaceutical industry, ensuring the stability of drug products is paramount. Drug stability refers to the ability of a pharmaceutical product to maintain its physical, chemical, therapeutic, and microbiological properties throughout its shelf …
In the high-stakes world of biosimilar development, manufacturers are increasingly turning to an unexpected partner: the Patent Trial and Appeal […]
Source
Biosimilar Patent Dance: Leveraging PTAB Challenges for Strategic Advantage Read Post »
Rare diseases have long been a challenge for the medical community, affecting millions of people worldwide. These diseases are often
Biotechnology’s Impact on Rare Diseases: A New Hope? Read Post »
Annual Drug Patent Expirations for ZORYVE Zoryve is a drug marketed by Arcutis and is included in two NDAs. It […]
Source
Annual Drug Patent Expirations for WEGOVY Wegovy is a drug marketed by Novo and is included in one NDA. It […]
Source
Annual Drug Patent Expirations for RETEVMO Retevmo is a drug marketed by Loxo Oncol Eli Lilly and is included in […]
Source
Get new actionable insights and updates from BiotechBlog
